| 5.54 0.34 (6.54%) | 10-07 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.65  |
1-year : | 7.77 |
| Resists | First : | 5.69 |
Second : | 6.65 |
| Pivot price | 4.75 |
|||
| Supports | First : | 4.59 |
Second : | 3.92 |
| MAs | MA(5) : | 4.97 |
MA(20) : | 4.6 |
| MA(100) : | 8.28  |
MA(250) : | 18.84 |
|
| MACD | MACD : | 0 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 81.6 |
D(3) : | 73.6 |
| RSI | RSI(14): 63.8 |
|||
| 52-week | High : | 36.41 | Low : | 3.92 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SNWV ] has closed above the upper band by 12.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 69.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 45 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.71 - 5.73 | 5.73 - 5.75 |
| Low: | 5.14 - 5.16 | 5.16 - 5.18 |
| Close: | 5.5 - 5.54 | 5.54 - 5.58 |
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Sun, 04 Oct 2026
SNWV Forecast — Price Target — Prediction for 2027 - TradingView
Fri, 02 Oct 2026
Fully vested at grant, 11,286 options go to SANUWAVE Health (SNWV) CEO Morgan C. Frank. - Stock Titan
Fri, 02 Oct 2026
Director Jeffrey Blizard receives 11,286 fully vested SANUWAVE Health (SNWV) stock options. - Stock Titan
Fri, 02 Oct 2026
SANUWAVE Health (SNWV) director Ian D. Miller receives 12,697 options, fully vested at grant. - Stock Titan
Fri, 02 Oct 2026
SANUWAVE Health, Inc. Common Stock (NASDAQ: SNWV) Stock Price, News & Analysis - Kalkine
Mon, 28 Sep 2026
Eden Prairie medical device maker receives Nasdaq delisting notice - The Business Journals
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 9 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 37.3 (%) |
| Shares Short | 305 (K) |
| Shares Short P.Month | 615 (K) |
| EPS | 0.81 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.2 |
| Profit Margin | 34.6 % |
| Operating Margin | -2.9 % |
| Return on Assets (ttm) | 5.5 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -3.1 % |
| Gross Profit (p.s.) | 3.9 |
| Sales Per Share | 5.11 |
| EBITDA (p.s.) | 0.49 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 5 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | 6.83 |
| PEG Ratio | 0 |
| Price to Book value | 26.38 |
| Price to Sales | 1.08 |
| Price to Cash Flow | 9.12 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|